Skip to main content
logo
Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea flag South Korea · Delayed Price · Currency is KRW
27,050
-400 (-1.46%)
At close: Aug 13, 2026

Aimed Bio Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
66,78947,27811,760171.21111.09
Revenue Growth
222.57%302.02%6768.70%54.12%-
Gross Profit
66,78947,27811,760171.21111.09
Operating Income
24,21820,769-407.75-6,416-5,592
Net Income
38,5965,023-3,304-9,023-6,168
Earnings Per Share
588.54101.00-93.00-264.18-184.51
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
92,666170,82835,51918,0816,018
Total Debt
1,5721,165425.57900.681,013
Net Cash (Debt)
91,094169,66335,09317,1805,006
Net Cash Growth
3.53%383.47%104.27%243.21%-
Net Cash Per Share
1389.473419.42987.82503.02149.73

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
10,77717,860-4,874-2,644-3,908
Capital Expenditures
-1,164-353.69-223.73-795.7-451.6
Free Cash Flow
9,61417,506-5,098-3,440-4,360
Free Cash Flow Growth
1155.67%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
36.26%43.93%-3.47%-3747.54%-5033.36%
Pretax Margin
42.50%-8.81%-28.17%-5273.93%-5589.37%
Profit Margin
57.79%10.62%-28.09%-5269.87%-5552.44%
FCF Margin
14.39%37.03%-43.35%-2009.11%-3924.65%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
45.32735.76---
P/FCF Ratio
181.97211.09---
PS Ratio
26.1978.16---